# Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses

> **NCT05674825** · PHASE1,PHASE2 · RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 400 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Targeted agent
- **DRUG:** Standard of care agent

## Key facts

- **NCT ID:** NCT05674825
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-21
- **Primary completion:** 2027-06
- **Final completion:** 2031-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674825, "Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor Prognoses". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05674825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*